# Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT)

> **NCT03535324** · NA · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 659 (actual)

## Conditions studied

- Antibiotic Resistant Infection

## Interventions

- **BEHAVIORAL:** PROA for optimization
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT03535324
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-05
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-05-31
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03535324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03535324, "Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03535324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*